High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer

High level expression of GR is strongly linked to prostate cancer aggressiveness in uni- and multivariate analysis. GR immunohistochemistry - alone or in combination with other markers - holds great potential to identify patients with a high risk for tumor progression.

Authors

Institutions

Publication Details

Journal
Prostate Cancer and Prostatic Diseases
Published
2025-11-05
DOI
https://doi.org/10.1038/s41391-025-01046-8
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer

Markus Graefen, Thorsten Schlomm, Katharina Möller, Maximilian Lennartz et al.
Prostate Cancer and Prostatic Diseases
Prostate Cancer Treatment and Research
article

High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer

Markus Graefen, Thorsten Schlomm, Katharina Möller, Maximilian Lennartz, Guido Sauter, Anne Menz, Florian Lutz, Eike Burandt, Andreas Marx, Stefan Steurer, Natalia Gorbokon, Christoph Fraune, Barbara Erber, Sarah Weinberger, Till Krech, Andreas M. Luebke, Sarah Jane Pauline Minner, Viktor Reiswich, Bernhard Ralla, Sören Weidemann, Simon Kind, Patrick Lebok, Frank Jacobsen, Waldemar Wilczak, Florian Viehweger, Hans Heinzer, Henning Plage, Nadine Biernath, Till Sebastian Clauditz, Morton Freytag, Christian Bernreuther, Ronald Simon, Andrea Hinsch, Alexander Haese, Viktoria Chirico, David Dum, Ria Schlichter, Neele Heckmann
article en

Abstract

High level expression of GR is strongly linked to prostate cancer aggressiveness in uni- and multivariate analysis. GR immunohistochemistry - alone or in combination with other markers - holds great potential to identify patients with a high risk for tumor progression.

Prostate Cancer and Prostatic DiseasesVol. 29(1)
Universität Hamburg (DE), University Medical Center Hamburg-Eppendorf (DE), Martini-Klinik (DE), Klinikum Fulda (DE), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 53%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.